Sun Pharmaceutical Entered Into Joint Venture with Intrexon Corporation

Sun Pharmaceutical Industries India's biggest drug maker by market capital and USA based Intrexon Corporation, a leading player in synthetic biology announced on 2 October 2013 to establish a joint venture to develop controllable gene-based therapies for the treatment of eye diseases.

The joint venture will helpful for Sun Pharma's  to increase their global capabilities and experience in developing and manufacturing complex dosage forms .It will also enhance their specialty pharmaceuticals for niche therapy areas.

The partners will initially work on  age related macular degeneration ( AMD)(a medical condition that causes partial or full loss of vision among older adults), glaucoma(a kind of eye disease) and retinitis pigmentosa(an eye disease that causes severe vision loss and at times even blindness).